Anthera Pharma (ANTH) Misses Q2 EPS by 4c
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
Anthera Pharma (NASDAQ: ANTH) reported Q2 EPS of ($0.35), $0.04 worse than the analyst estimate of ($0.31).
For earnings history and earnings-related data on Anthera Pharma (ANTH) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AK Steel (AKS) Pares Earlier Gains, Shares Whipsaw
- Waters Corp. (WAT) Tops Q4 EPS by 8c
- Allegheny Technologies (ATI) Reports Q4 Loss of $0.04
Create E-mail Alert Related CategoriesEarnings
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!